HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna K Kopec Selected Research

estropipate (Ogen)

1/2022Cross-linking by tissue transglutaminase-2 alters fibrinogen-directed macrophage proinflammatory activity.
1/2019Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans.
8/2017Thrombin promotes diet-induced obesity through fibrin-driven inflammation.
1/2017Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12.
6/2016Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna K Kopec Research Topics

Disease

9Liver Diseases (Liver Disease)
11/2021 - 05/2014
9Necrosis
12/2020 - 03/2008
8Inflammation (Inflammations)
01/2022 - 10/2011
7Fibrosis (Cirrhosis)
11/2021 - 06/2014
4Liver Cirrhosis (Hepatic Cirrhosis)
11/2021 - 10/2014
4Hyperplasia
01/2016 - 09/2011
3Fatty Liver
08/2017 - 11/2014
3Neoplasms (Cancer)
07/2012 - 09/2011
2Obesity
01/2020 - 08/2017
2Autoimmune Diseases (Autoimmune Disease)
01/2018 - 01/2017
2Non-alcoholic Fatty Liver Disease
12/2016 - 11/2014
2Body Weight (Weight, Body)
12/2016 - 11/2014
2Hypertrophy
10/2011 - 03/2010
1Hyperinsulinism (Hyperinsulinemia)
12/2020
1Glomerulonephritis
01/2018
1Hemorrhage
01/2018
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2018
1Weight Gain
08/2017
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2017
1Cholestasis
01/2017
1Chronic Disease (Chronic Diseases)
06/2016
1Thrombosis (Thrombus)
06/2016
1Hypoxia (Hypoxemia)
01/2015
1Cholangitis
10/2014
1Carcinogenesis
09/2011
1Cysts
01/2009

Drug/Important Bio-Agent (IBA)

9FibrinIBA
01/2022 - 11/2014
5estropipate (Ogen)FDA LinkGeneric
01/2022 - 06/2016
41-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA
11/2021 - 01/2016
4Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2009
4ThrombinFDA Link
01/2018 - 11/2014
3Blood Coagulation Factors (Coagulation Factor)IBA
01/2022 - 05/2014
3Hemostatics (Antihemorrhagics)IBA
11/2021 - 06/2016
3Polychlorinated Dibenzodioxins (TCDD)IBA
12/2016 - 10/2011
3Drinking WaterIBA
07/2012 - 09/2011
3chromium hexavalent ionIBA
07/2012 - 09/2011
2Carbon Tetrachloride (Tetrachloromethane)IBA
11/2021 - 01/2017
2von Willebrand FactorIBA
11/2021 - 01/2017
2Fibrinogen (Factor I)FDA Link
01/2019 - 08/2017
2Acetaminophen (Paracetamol)FDA LinkGeneric
01/2018 - 01/2017
2Peptide Hydrolases (Proteases)FDA Link
01/2018 - 12/2016
2Plasminogen Activators (Plasminogen Activator)IBA
01/2018 - 06/2014
2AntithrombinsIBA
08/2017 - 11/2014
2DabigatranFDA Link
08/2017 - 11/2014
2XenobioticsIBA
01/2017 - 01/2016
2Messenger RNA (mRNA)IBA
01/2017 - 10/2014
2Trichloroethylene (Trichloroethene)IBA
01/2017 - 10/2014
2CytokinesIBA
12/2016 - 01/2016
2Collagen Type I (Type I Collagen)IBA
10/2014 - 01/2009
22,4,5,2',4',5'-hexachlorobiphenylIBA
10/2011 - 03/2010
1EnzymesIBA
12/2020
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2018
1Docosahexaenoic AcidsIBA
01/2018
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2018
1CaspasesIBA
01/2018
1AutoantibodiesIBA
01/2018
1Plasminogen Activator Inhibitor 1IBA
01/2018
1Factor Xa (Coagulation Factor Xa)IBA
01/2018
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018
1Protease Inhibitors (Protease Inhibitor)IBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
08/2017
1ThrombomodulinIBA
08/2017
1AntibodiesIBA
01/2017
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
12/2016
1Thrombin Receptors (Thrombin Receptor)IBA
12/2016
1AnticoagulantsIBA
06/2016
1Clopidogrel (Plavix)FDA Link
01/2016
1InterferonsIBA
01/2016
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2016
1IntegrinsIBA
01/2016
1leukadherin-1IBA
01/2016
1Purinergic P2Y Receptor AntagonistsIBA
01/2016
1TransglutaminasesIBA
01/2016
1Transcription Factors (Transcription Factor)IBA
01/2015
1Oxygen (Dioxygen)IBA
01/2015
1Bile Acids and Salts (Bile Acids)IBA
11/2014
1Pharmaceutical PreparationsIBA
06/2014
1Tranexamic Acid (AMCA)FDA Link
06/2014
1Antifibrinolytic Agents (Antifibrinolytics)IBA
06/2014
1Alanine Transaminase (SGPT)IBA
10/2013
1dibenzo(1,4)dioxinIBA
10/2013
1sodium bichromate (sodium dichromate)IBA
02/2012
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2009
1CollagenIBA
01/2009
13,4,5,3',4'-pentachlorobiphenylIBA
03/2008